SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001213900-12-003016
Filing Date
2012-05-25
Accepted
2012-05-24 19:24:43
Documents
9
Period of Report
2011-12-31
Filing Date Changed
2012-05-24

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2011_regenocell.htm 10-K 1165091
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT f10k2011ex31i_regenocell.htm EX-31.1 11348
3 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT f10k2011ex32i_regenocell.htm EX-32.1 5501
  Complete submission text file 0001213900-12-003016.txt   2960838

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rcll-20111231.xml EX-101.INS 300796
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcll-20111231.xsd EX-101.SCH 17836
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT. rcll-20111231_cal.xml EX-101.CAL 20331
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcll-20111231_def.xml EX-101.DEF 11451
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT. rcll-20111231_lab.xml EX-101.LAB 156665
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT. rcll-20111231_pre.xml EX-101.PRE 87471
Mailing Address 2 BRIAR LANE NATICK, MA 01760
Business Address 2 BRIAR LANE NATICK, MA 01760 508-647-4065
RegenoCELL Therapeutics, Inc. (Filer) CIK: 0001221749 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50639 | Film No.: 12869002
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1